|
LGALS8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.502000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.839000E-01 |
| Normal-vs-Stage2 |
3.285200E-01 |
| Normal-vs-Stage3 |
7.515800E-01 |
| Normal-vs-Stage4 |
3.446000E-01 |
| Stage1-vs-Stage2 |
8.036100E-02 |
| Stage1-vs-Stage3 |
4.952000E-01 |
| Stage1-vs-Stage4 |
8.904600E-01 |
| Stage2-vs-Stage3 |
2.155000E-01 |
| Stage2-vs-Stage4 |
9.456400E-02 |
| Stage3-vs-Stage4 |
5.134800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.834800E-01 |
| Normal-vs-AfricanAmerican |
5.823000E-01 |
| Normal-vs-Asian |
3.761400E-01 |
| Caucasian-vs-AfricanAmerican |
9.289000E-01 |
| Caucasian-vs-Asian |
8.870800E-01 |
| AfricanAmerican-vs-Asian |
9.899800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.706400E-01 |
| Normal-vs-Female |
3.847600E-01 |
| Male-vs-Female |
5.799200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.304450E-01 |
| Normal-vs-Age(41-60Yrs) |
8.650600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.244800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.343600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.334770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.367000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.554800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.339200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.150400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.753000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.130600E-01 |
| Classical-VS-Follicular |
4.85850248921338E-11 |
| Classical-VS-Other |
9.192500E-02 |
| Classical-VS-Normal |
1.609660E-02 |
| Tall-VS-Follicular |
1.042300E-03 |
| Tall-VS-Other |
1.491610E-01 |
| Tall-VS-Normal |
4.425800E-01 |
| Follicular-VS-Other |
7.211800E-01 |
| Follicular-VS-Normal |
1.737590E-03 |
| Other-VS-Normal |
2.377800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.449800E-01 |
| Normal-vs-N1 |
3.018400E-01 |
| N0-vs-N1 |
1.084850E-01 |
|
|
